Experts in the News

The Corbevax vaccine, developed by fellow Peter Hotez and Maria Elena Bottazzi, co-directors of the Texas Children’s Hospital Center for Vaccine Development, could be used to fill the vaccine supply gap in low-income countries. Hotez explained why vaccinating the world is humanitarian and "in our enlightened self-interest."

“We’ve given new variants an opportunity to arise," said fellow Peter Hotez as he discussed the Pfizer vaccine's effectiveness against the Delta variant, the future of booster shots and the need for increased immunization.

"We don’t need an intelligence report, we need an outbreak investigation — and that’s a very different skill set, and a very different approach," said health policy fellow Peter Hotez on efforts to determine the origin of COVID-19.

"I’m extremely optimistic for the country," said health policy fellow Peter Hotez of the prospects for the months ahead. "I think that by the summer, we’re going have something that resembles a normal quality of life."  

"There’s going to have to be a lot of public communication, and a lot of advocacy, because parents are going to be a bit skittish about ... a brand new mRNA technology for their kids,” said Hotez. But vaccinating children will be key to curbing COVID, he added.